Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1429, 2004-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Intensive statin therapy reduces HF risk in ACS
Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. :
Access to resources
Recommend
Intensive statin therapy tops standard for CAD, ACS
Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. :
Cost effectiveness of intensive statin therapy remains debatable
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. :
Cardiovascular benefits from statin therapy may be mediated by anti-inflammatory effects
Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. :